Modus Therapeutics Holding: Raising cash – Q2 review
11 augusti, 06:52
11 augusti, 06:52
DNB Carnegie has published a new commissioned research report on Modus Therapeutics Holding.
To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/modus/
Information
This is a press release from DNB Carnegie. For information about DNB Carnegie commissioned research, see https://www.carnegie.se/en/commissioned-research/, or contact our commissioned research team at cr@carnegie.se.
About Us
DNB Carnegie is the leading and independent Nordic investment and private bank. Our operations within Corporate Finance, Securities and Research, Private Banking and Wealth Management are among the market leaders within their respective sectors. Together, they build an unbeatable combination of integrated knowledge, guiding our clients towards better business. DNB Carnegie operates in six countries and has more than 800 employees.
11 augusti, 06:52
DNB Carnegie has published a new commissioned research report on Modus Therapeutics Holding.
To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/modus/
Information
This is a press release from DNB Carnegie. For information about DNB Carnegie commissioned research, see https://www.carnegie.se/en/commissioned-research/, or contact our commissioned research team at cr@carnegie.se.
About Us
DNB Carnegie is the leading and independent Nordic investment and private bank. Our operations within Corporate Finance, Securities and Research, Private Banking and Wealth Management are among the market leaders within their respective sectors. Together, they build an unbeatable combination of integrated knowledge, guiding our clients towards better business. DNB Carnegie operates in six countries and has more than 800 employees.
Börsernas utveckling
Wingefors försäljning
Börsen
Styrräntan
Aktieanalyser
Börsernas utveckling
Wingefors försäljning
Börsen
Styrräntan
Aktieanalyser
1 DAG %
Senast
OMX Stockholm 30
1 DAG %
Senast
2 612,89